| Aktie | Ticker | Breite | GCS | 2026/Q1 | 2025/Q4 | 2025/Q3 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | ||||
| 1.010.581.941 $ | +295.950.455 $ | +46,0 % | 2 | 714.631.486 $ | -43.589.839 $ | -8,8 % | 2 | 758.221.325 $ | -172.008.130 $ | +6,9 % | 2 | ||||
| CAVA GROUP, INC. | CAVA | → 0 | Neutral | 769.196.391 $ | +211.172.458 $ | +37,8 % | 1 | 558.023.933 $ | -16.353.743 $ | -2,8 % | 1 | 574.377.676 $ | -226.480.322 $ | -28,3 % | 1 |
| LEXICON PHARMACEUTICALS, INC. | LXRX | → 0 | Neutral | 241.385.550 $ | +84.777.997 $ | +54,1 % | 1 | 156.607.553 $ | -27.236.096 $ | -14,8 % | 1 | 183.843.649 $ | +54.472.192 $ | +42,1 % | 1 |
| 1.010.581.941 $ | +295.950.455 $ | +46,0 % | 2 | 714.631.486 $ | -43.589.839 $ | -8,8 % | 2 | 758.221.325 $ | -172.008.130 $ | +6,9 % | 2 | ||||